Metis

Halal Rating :
Comfortable
Contract: 0x9E32b13ce7f2E80A01932B42553652E053D6ed8e
Last Price $16.0 Last updated:
Rank 310
1D Change -9.56 %
Market Cap $99.87m
Circulating supply 6,255,334
Maximum supply None

Crypto Overview

Categories
  • Zero Knowledge Proofs
  • Scaling
  • Ethereum Ecosystem
  • Layer 2
  • Rollups
  • OKX Ventures Portfolio
  • MetisDAO Ecosystem
  • DWF Labs Portfolio
  • Metis Andromeda Ecosystem

Overview

Metis is a Layer 2 scaling solution for Ethereum that aims to provide faster and cheaper transactions while maintaining Ethereum's security. It uses Optimistic Rollup technology to achieve this goal.

Purpose and Utility

The primary purpose of METIS is to serve as the native token of the Metis platform, used for transaction fees, staking, and governance. The token has clear utility within its ecosystem, being necessary for network operations and securing the platform.

Business Model Analysis

The platform's business model focuses on providing blockchain infrastructure services, particularly helping businesses and developers deploy decentralized applications more efficiently. This aligns with halal principles as it provides genuine utility and involves the exchange of real value.

Real-World Adoption

Metis has established partnerships with various projects and continues to see growing adoption in the DeFi space. The platform hosts multiple decentralized applications and maintains active development.

Platform Development

The project maintains regular development activity, with frequent updates to its infrastructure and technical documentation. The GitHub repository shows consistent contributions, indicating ongoing technical progress.

Token Distribution

The token distribution includes allocations for development, ecosystem growth, and community initiatives. While there is some concentration of tokens among early participants, vesting schedules are in place to prevent sudden selling pressure.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments

0 Comments

Login to join the discussion